| Kevin K Matsuba, MD | |
|
2314 Nw Kings Blvd, Corvallis, OR 97330-3925 | |
| (541) 758-5047 | |
| (541) 758-3713 |
| Full Name | Kevin K Matsuba |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2314 Nw Kings Blvd, Corvallis, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376500710 | NPI | - | NPPES |
| 297559 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD24745 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kevin K Matsuba, MD 2314 Nw Kings Blvd, Po Box 1418, Corvallis, OR 97330-3925 Ph: (541) 758-5047 | Kevin K Matsuba, MD 2314 Nw Kings Blvd, Corvallis, OR 97330-3925 Ph: (541) 758-5047 |
News Archive
Researchers from the University of Chicago have shown that inhibiting autophagy, a self-devouring process used by cells to degrade large intra-cellular cargo, effectively blocks tumor cell migration and breast cancer metastasis in tumor models.
A new online tool from the Center on Alcohol Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg School of Public Health determines the extent of exposure to radio alcohol advertisements among young people ages 12 to 20 in 75 different media markets.
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
Fetal Alcohol Spectrum Disorders affects approximately 1 in 20 children in the United States. These catastrophic and irreversible disorders are entirely preventable if no alcohol is used during pregnancy.
› Verified 9 days ago
Mr. James C Dunn, Radiology Medicare: Accepting Medicare Assignments Practice Location: 2314 Nw Kings Blvd # A, Corvallis, OR 97330 Phone: 541-758-5047 Fax: 541-758-3713 | |
Bruce E Frey, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 501 Nw Elks Dr, Corvallis, OR 97330 Phone: 541-768-5220 Fax: 541-768-5303 | |
Mary M Austin-seymour, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 501 Nw Elks Dr, Corvallis, OR 97330 Phone: 541-768-5220 | |
Charles Bg Knight, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2314 Nw Kings Blvd # A, Corvallis, OR 97330 Phone: 541-758-5047 Fax: 541-758-3713 | |
Dr. Kate Taylor Doyle, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1121 Sw Sunset Dr, Corvallis, OR 97333 Phone: 952-595-1100 Fax: 952-942-3361 | |
Leslie Ann Arpin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2314 Nw Kings Blvd Ste A, Corvallis, OR 97330 Phone: 541-758-5047 Fax: 541-758-3713 | |
Jefferson A Hamlin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2314 Nw Kings Blvd, Corvallis, OR 97330 Phone: 541-758-5047 Fax: 541-758-3713 |